TBPH Theravance Biopharma, Inc.
Healthcare$16.41+0.24%ClosedMarket Cap: $846.0M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
4
Dispositions
5
Buy/Sell Ratio
0.80
Net Shares
+118,708
Shares Acquired
168,750
Shares Disposed
50,042
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri May 22 | Winningham Rick E | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 20,038 | $16.55 | 1,631,056 |
| Fri May 22 | Sawaf Aziz | officer: SVP & CHIEF FINANCIAL OFFICER | Sell | 8,670 | $16.55 | 344,953 |
| Fri May 22 | Miller Aine | officer: SVP, DEV & HEAD OF IRE OFFICE | Sell | 6,827 | $16.55 | 177,334 |
| Fri May 22 | Grimaud Brett A. | officer: SVP, GEN COUNSEL AND SECRETARY | Sell | 8,829 | $16.55 | 363,120 |
| Fri May 22 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | Sell | 5,678 | $16.55 | 245,771 |
| Fri Apr 03 | Winningham Rick E | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 75,000 | $0.00 | 1,651,094 |
| Fri Apr 03 | Sawaf Aziz | officer: SVP & CHIEF FINANCIAL OFFICER | Sell | 37,500 | $0.00 | 353,623 |
| Fri Apr 03 | Grimaud Brett A. | officer: SVP, GEN COUNSEL AND SECRETARY | Sell | 37,500 | $0.00 | 371,949 |
| Fri Apr 03 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | Sell | 18,750 | $0.00 | 251,449 |
| Wed Mar 18 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | Sell | 15,534 | $14.00 | 240,465 |
| Wed Mar 18 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | Sell | 7,767 | $13.92 | 255,999 |
| Wed Mar 18 | Farnum Rhonda | officer: SVP, COMM & MEDICAL AFFAIRS | Sell | 7,766 | $13.92 | 232,699 |
| Tue Feb 24 | Winningham Rick E | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 74,975 | $19.66 | 1,576,094 |
| Tue Feb 24 | Sawaf Aziz | officer: SVP & CHIEF FINANCIAL OFFICER | Sell | 20,672 | $19.66 | 316,123 |
| Tue Feb 24 | Miller Aine | officer: SVP, DEV & HEAD OF IRE OFFICE | Sell | 16,851 | $19.66 | 184,161 |